Baropozitone 5/160 mg

Adult dose

The recommended dosage for this medication is 1 tablet once daily, taken with water regardless of meals. It is advised to take it at the same time every day (e.g., morning). The dosage may be adjusted to appropriate levels of 5/80 mg, 5/160 mg, or 10/160 mg based on blood pressure control. In patients with kidney impairment, dosage adjustment is necessary for mild to moderate impairment (creatinine clearance greater than 10 mL/min).

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, and its administration is not recommended.

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. This medication should not be used by women who are allergic to the active ingredients, pregnant, breastfeeding, or patients with severe kidney or liver dysfunction. Patients with low sodium or fluid may experience hypotension; thus, their condition should be corrected before taking this medication, and careful monitoring is required during administration. Patients with high potassium levels should be cautious when taking this medication together with potassium supplements or medications that can increase potassium levels, and potassium levels should be monitored regularly. Patients with kidney problems or those who have undergone kidney transplantation should closely monitor kidney function changes when using this medication. If symptoms of angioedema occur, the medication should be discontinued immediately, and re-administration should be avoided. Patients with heart failure or those recovering from myocardial infarction require careful monitoring, including evaluation of kidney function. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. This medication may interact with other antihypertensives, potassium supplements, diuretics, and non-steroidal anti-inflammatory drugs, so it is essential to consult a physician or pharmacist about concurrent use of any other medications. In case of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur; thus, if any abnormal symptoms arise, a healthcare facility should be visited immediately. This medication is not recommended for patients under 18 years of age as its safety and effectiveness have not been sufficiently established. Elderly patients can be administered similar dosages as general adults, but careful monitoring is necessary.

Serious side effects

Urticaria, severe swelling (edema), angioedema, airway obstruction and/or swelling of the face, lips, and tongue, Stevens-Johnson syndrome, liver function tests elevation, jaundice, kidney failure, acute kidney failure, increased serum creatinine, syncope, severe allergic reactions, severe edema or urination abnormalities, serious neurological symptoms, pulmonary edema, vasculitis, thrombocytopenia, leukopenia, serum sickness, worsening heart failure, abdominal

Mild side effects

• Pharyngitis
• influenza
• visual disturbances
• anxiety
• headache
• dizziness
• drowsiness
• orthostatic dizziness
• paresthesia
• vertigo

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage ensures the medication's effectiveness and safety for a longer period.

Appearance

Dark yellow rectangular film-coated tablet

Package unit

30 tablets/bottle